A case in point is the activation of the EMT program in IL-1β-induced non-small cell lung cancer (NSCLC) that facilitates epigenetic alterations at the E-cadherin gene promoter (Li R. et al., 2020). The gene discussed is IL1B; the disease is non-small cell lung carcinoma.